Alessandro Conti

2.6k total citations
81 papers, 1.6k citations indexed

About

Alessandro Conti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Alessandro Conti has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 20 papers in Surgery. Recurrent topics in Alessandro Conti's work include Renal cell carcinoma treatment (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Alessandro Conti is often cited by papers focused on Renal cell carcinoma treatment (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Alessandro Conti collaborates with scholars based in Italy, United States and Spain. Alessandro Conti's co-authors include Matteo Santoni, Stefano Cascinu, Luciano Burattini, Giovanni Muzzonigro, Rodolfo Montironi, Rossana Berardi, Daniele Minardi, Francesco Massari, Daniele Santini and Giampaolo Tortora and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alessandro Conti

79 papers receiving 1.5k citations

Peers

Alessandro Conti
Alessandro Conti
Citations per year, relative to Alessandro Conti Alessandro Conti (= 1×) peers René Baumann

Countries citing papers authored by Alessandro Conti

Since Specialization
Citations

This map shows the geographic impact of Alessandro Conti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Conti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Conti more than expected).

Fields of papers citing papers by Alessandro Conti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Conti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Conti. The network helps show where Alessandro Conti may publish in the future.

Co-authorship network of co-authors of Alessandro Conti

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Conti. A scholar is included among the top collaborators of Alessandro Conti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Conti. Alessandro Conti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattavelli, Davide, et al.. (2024). Squamous cell carcinoma of the nasal vestibule: a diagnostic and therapeutic challenge. European Archives of Oto-Rhino-Laryngology. 281(11). 5627–5640. 2 indexed citations
2.
Mistretta, Francesco Alessandro, Claudia Collà Ruvolo, Alessandro Conti, et al.. (2020). Robot-assisted intracorporeal orthotopic ileal neobladder: Description of the “Shell” technique. European Urology Open Science. 19. e2351–e2351. 2 indexed citations
3.
Berardi, Rossana, Gaia Goteri, Vittorio Paolucci, et al.. (2020). The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions. Journal of Thoracic Disease. 12(12). 7245–7256. 2 indexed citations
4.
Nunno, Vincenzo Di, Matteo Santoni, Veronica Mollica, et al.. (2020). Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients. Clinical Drug Investigation. 40(3). 211–226. 12 indexed citations
5.
Gazzini, Luca, et al.. (2019). Endoscopic stapedotomy: safety and audiological results in 150 patients. European Archives of Oto-Rhino-Laryngology. 277(1). 85–92. 25 indexed citations
6.
Santoni, Matteo, Francesco Massari, Vincenzo Di Nunno, et al.. (2018). Immunotherapy in renal cell carcinoma: latest evidence and clinical implications. PMC. 1 indexed citations
7.
Giulietti, Matteo, Giulia Occhipinti, Massimo Bracci, et al.. (2018). Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data. Frontiers in Oncology. 8. 450–450. 43 indexed citations
8.
Conti, Alessandro, et al.. (2017). Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials. PLoS ONE. 12(8). e0183639–e0183639. 3 indexed citations
9.
Castiglione, Giacomo, et al.. (2016). Focal epilepsy as a long term sequela of Parvovirus B19 encephalitis. Journal of Clinical Virology. 80. 20–23. 3 indexed citations
10.
Santoni, Matteo, Alessandro Conti, Francesco Piva, et al.. (2015). Role of STAT3 pathway in genitourinary tumors. PMC. 1 indexed citations
11.
Conti, Alessandro, Matteo Santoni, Luciano Burattini, et al.. (2015). Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis. Urologic Oncology Seminars and Original Investigations. 33(7). 303–309. 13 indexed citations
12.
Massari, Francesco, Matteo Santoni, Chiara Ciccarese, et al.. (2015). Emerging concepts on drug resistance in bladder cancer: Implications for future strategies. Critical Reviews in Oncology/Hematology. 96(1). 81–90. 66 indexed citations
13.
Massari, Francesco, Chiara Ciccarese, Matteo Santoni, et al.. (2015). The route to personalized medicine in bladder cancer: where do we stand?. Targeted Oncology. 10(3). 325–336. 14 indexed citations
14.
Santoni, Matteo, Alessandro Conti, Luciano Burattini, et al.. (2014). Neuroendocrine differentiation in prostate cancer: Novel morphological insights and future therapeutic perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846(2). 630–637. 49 indexed citations
15.
Lacetera, Vito, et al.. (2014). Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy. Archivio Italiano di Urologia e Andrologia. 86(4). 332–332. 16 indexed citations
16.
Santoni, Matteo, Francesco Pantano, Consuelo Amantini, et al.. (2014). Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1845(2). 221–231. 49 indexed citations
17.
Santoni, Matteo, Ugo De Giorgi, Roberto Iacovelli, et al.. (2013). Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. British Journal of Cancer. 109(7). 1755–1759. 74 indexed citations
18.
Polito, Massimo, Gianluca d’Anzeo, Alessandro Conti, & Giovanni Muzzonigro. (2012). Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates. British Journal of Urology. 110(11c). E954–7. 33 indexed citations
19.
Selli, Cesare, et al.. (2007). Value of image fusion in the staging of prostatic carcinoma. La radiologia medica. 112(1). 74–81. 8 indexed citations
20.
Rosenberg, Joel, et al.. (1989). Blunt Injuries to the Aortic Arch Vessels. The Annals of Thoracic Surgery. 48(4). 508–513. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026